Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Page 68 - Sohini Das
Paid Covid-19 booster shots: Experts divided on govt intervention
Centre may have to step in to ensure universal coverage, some say; also call for shift in focus to strengthen surveillance, testing and gathering data
 "Paid Covid-19 booster shots: Experts divided on govt intervention")
Boosters for all: Pvt hospitals in a bind over new pricing, old vax stocks
Some Kolkata hospitals have decided to go with the new pricing from Monday on the basis of discussions.
 "Boosters for all: Pvt hospitals in a bind over new pricing, old vax stocks")
Govt okays booster Covid shot for all adults at private centres from Apr 10
Around 22.8 mn precaution or booster dose have been administered to healthcare and frontline workers along with senior citizens after the population segments opened up in the first week of January.
 "Govt okays booster Covid shot for all adults at private centres from Apr 10")
India's major drug players bet on new brand launches, shows data
Industry insiders say brand launches are the lifeline of the pharma industry, and ensure steady volume growth and market share
 "India's major drug players bet on new brand launches, shows data")
INSACOG testing sewage water samples across 55 sites to detect Sars-CoV-2
'This is called environmental surveillance, and India has done this during the polio campaign,' said N K Arora, co-chair, INSACOG
 "INSACOG testing sewage water samples across 55 sites to detect Sars-CoV-2")
India's 1st Covid variant XE case in Mumbai: Civic body and Centre differ
BMC declares results of 11th genome sequencing done by it. One sample tested positive for XE strain, another tested positive for Kappa variant
 "India's 1st Covid variant XE case in Mumbai: Civic body and Centre differ")
Decoded: How WHO's mRNA Tech Transfer Hub is working for vaccine access
After examining several proposals from India, Hyderabad-based Biological E has now been selected to partner with WHO to make mRNA technology-based vaccines in the country
 "Decoded: How WHO's mRNA Tech Transfer Hub is working for vaccine access")
After 715 days, India reports less than 1,000 daily fresh Covid-19 cases
Experts think that daily cases are unlikely to spike, leading to a 'wave', in the short term, and that the pandemic appears to be over.
 "After 715 days, India reports less than 1,000 daily fresh Covid-19 cases")
Biological E recipient of mRNA tech as part of WHO's tech transfer hub
WHO and partners to work with Indian govt and the firm to develop roadmap and put in place training and support for Biological E to start producing mRNA vaccines at the earliest
 "Biological E recipient of mRNA tech as part of WHO's tech transfer hub")
SII, Bharat Biotech halt production of Covid vaccines as demand slips
High inventory, lack of fresh orders behind the decision; focus on non-Covid vax
 "SII, Bharat Biotech halt production of Covid vaccines as demand slips")
No issue with Covaxin certificate: Bharat Biotech on WHO suspending vaccine
Bharat biotech says there are no issues with Covaxin or its certification, further we will focus on pending facility maintenance, has no supply commitments pending for UN agency.
 "No issue with Covaxin certificate: Bharat Biotech on WHO suspending vaccine")
KKR-backed JB Chemicals bets big on lozenges and probiotic products
JB Chemicals now plan to enter new areas like sleep disorders, sexual wellness, motion sickness, and immunity apart, from the conventional areas like cough, sore throat, etc.
 "KKR-backed JB Chemicals bets big on lozenges and probiotic products")
US lawsuit may not impact India launch of Gennova's mRNA vaccine
The vaccine is now under review by the regulator, and if approved, it may be ready for launch in the Indian market and will be the first mRNA Covid vaccine to be available here.
Bharat Biotech slows down Covaxin production as it sees decrease in demand
'For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities,' the Hyderabad-based company said
 "Bharat Biotech slows down Covaxin production as it sees decrease in demand")
Lupin's New Jersey facility gets 13 US FDA observations
The observations do not, however, imply any restriction on supplies
 "Lupin's New Jersey facility gets 13 US FDA observations")
Bulk of pharma growth came from price hikes, shows data
The average increase in prices was 3.1 per cent in the past five years.
 "Bulk of pharma growth came from price hikes, shows data")
Demand for chronic drugs likely to rise 30% ahead of price hike
There would be a general rise in demand for chronic medicines as consumers would stock up ahead of a price rise
 "Demand for chronic drugs likely to rise 30% ahead of price hike")
States begin doing away with Covid restrictions; Delhi removes no-mask fine
Some states like Tamil Nadu are, however, taking a cautious approach, and are yet to announce major relaxations
 "States begin doing away with Covid restrictions; Delhi removes no-mask fine")
Vaccine policy group seeks more lab data on tests for mixing Covid doses
NTAGI has a month to go before it gives its advice to the government on inoculation strategy.
Pharma SMEs stock up on a month's raw material amid supply disruptions
The lockdown in various Chinese provinces, including Shanghai, is likely to delay shipments by two weeks to a month, said domestic players.
